Baupost Group Drops Targacept While SAC Buys Amarin


Several major investors made moves in the pharmaceuticals arena last week as the ups and downs in that industry came to the fore. The Baupost Group sold off its entire holdings of the Biotechnology firm Targacept Inc. (NASDAQ:TRGT) and SAC Capital advisers continued to increase its stake in the pharmaceuticals research firm Amarin Corporation plc (NYSE:AMRN). Both pieces of news . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Subscribe to our mailing list

* indicates required

Opt of of ocassional 3rd party offers

Congrats! We have a limited time offer for loyal readers like yourself.

Sign up today and get three months free if you select yearly subscription

Use coupon code 3monthsfreeconfidential at checkout

Limited time offer only expires 3/31/2019 or next 30 subscribers whichever comes first – please do not share this discount with others